Type I interferon therapies of multiple sclerosis and hepatitis C virus infection
By:
Authors
Izabella Jasyk
Izabella.jasyk@port.lukasiewicz.gov.pl
Laboratory of Microbiome Immunobiology, Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wroclaw, Poland
Bioengineering Research Group, Łukasiewicz Research Network-PORT Polish Center for Technology Development, Wroclaw, Poland
Jakub Siednienko
Bioengineering Research Group, Łukasiewicz Research Network-PORT Polish Center for Technology Development, Wroclaw, Poland
DOI: https://doi.org/10.2478/ahem-2021-0001 | Journal eISSN: 1732-2693
Language: English
Page range: 537 - 547
Submitted on: Nov 16, 2020
Accepted on: Apr 23, 2021
Published on: Oct 21, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2021 Izabella Jasyk, Jakub Siednienko, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.